Dermira, Inc. Shares(1) Common Stock ($0.001 par value) Underwriting AgreementUnderwriting Agreement • September 19th, 2014 • Dermira, Inc. • Pharmaceutical preparations • New York
Dermira, Inc., a corporation organized under the laws of the State of Delaware (the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, shares of common stock, $0.001 par value (“Common Stock”) of the Company (said shares to be issued and sold by the Company being hereinafter called the “Underwritten Securities”). The Company also proposes to grant to the Underwriters an option to purchase up to additional shares of Common Stock to cover over-allotments, if any (the “Option Securities”; the Option Securities, together with the Underwritten Securities, being hereinafter called the “Securities”). To the extent there are no additional Underwriters listed on Schedule I other than you, the term Representatives as used herein shall mean you, as Underwriters, and the terms Representatives and Underwriters shall mean either the singular or plural as the context requires. Ce
INDEMNITY AGREEMENTIndemnity Agreement • September 19th, 2014 • Dermira, Inc. • Pharmaceutical preparations • Delaware
This Indemnity Agreement, dated [ ], 20[ ] is made by and between Dermira, Inc., a Delaware corporation (the “Company”), and [ ], a director, officer or key employee of the Company or Subsidiary who satisfies the definition of Indemnifiable Person set forth below (“Indemnitee”).
DERMIRA, INC. LOAN AND SECURITY AGREEMENTLoan and Security Agreement • September 19th, 2014 • Dermira, Inc. • Pharmaceutical preparations • California
Prior Names (Section 5.5) — Borrower did business as “Skintelligence, Inc.” from the date of incorporation on August 18, 2010 until Borrower changed its name to “Dermira, Inc.” pursuant to filing a Certificate of Amendment of Restated Certificate of Incorporation with the Secretary of State of the State of Delaware on September 9, 2011.
